e-Drug3D 616 |
cas 75330-75-5 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
NATURAL MOLECULE (link) | PK parameters F 30 PERCENT Solubility INSOLUBLE IN WATER |
Target TARGET 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE PDB Ligand code = 803 (link to the list of PDB complexes) Download experimental 3D coordinates of 803 with added hydrogens |
DrugCentral 3-hydroxy-3-methylglutaryl-coenzyme A reductase UNIPROT P04035 HMGCR |
Download SDF file | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate Formula: Calculated chemical properties: MW 404.53 NB_atoms 29 XLogP 4.20 PSA 67.515 NB_HD 1 NB_HA 5 fsp3 0.75 Lipinski(0=no;1=yes) 1 |
FDA NDA 019643 (label) INN (LOVASTATIN) MEVACOR (MERCK) APPROVAL= AP YEAR= 1987 DISCONTINUED NDA 021249 (label) INN (LOVASTATIN) ADVICOR (ABBVIE) APPROVAL= AP YEAR= 2001 OBSOLETE NDA 075300 (pdf not found) INN (LOVASTATIN) LOVASTATIN (CHARTWELL RX) APPROVAL= AP YEAR= 2001 NDA 075451 (pdf not found) INN (LOVASTATIN) LOVASTATIN (AUROBINDO PHARMA USA) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 075551 (pdf not found) INN (LOVASTATIN) LOVASTATIN (TEVA) APPROVAL= AP YEAR= 2001 NDA 075636 (pdf not found) INN (LOVASTATIN) LOVASTATIN (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2001 NDA 075828 (pdf not found) INN (LOVASTATIN) LOVASTATIN (ACTAVIS ELIZABETH) APPROVAL= AP YEAR= 2001 NDA 075935 (pdf not found) INN (LOVASTATIN) LOVASTATIN (AUROBINDO PHARMA USA) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 021316 (label) INN (LOVASTATIN) ALTOPREV (COVIS) APPROVAL= AP YEAR= 2002 DISCONTINUED NDA 075991 (pdf not found) INN (LOVASTATIN) LOVASTATIN (CARLSBAD) APPROVAL= AP YEAR= 2002 NDA 077520 (pdf not found) INN (LOVASTATIN) LOVASTATIN (SUN PHARM INDUSTRIES) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 077748 (pdf not found) INN (LOVASTATIN) LOVASTATIN (COREPHARMA) APPROVAL= AP YEAR= 2007 NDA 078296 (pdf not found) INN (LOVASTATIN) LOVASTATIN (LUPIN) APPROVAL= AP YEAR= 2007 |
Other links: |